- IMRX -2.11%
We Think Immuneering (NASDAQ:IMRX) Needs To Drive Business Growth Carefully
Yahoo Finance · 3 weeks ago
Open | 1.4400 |
High | 1.4500 |
Low | 1.3600 |
Mkt Cap | 42.11M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.4200 |
52 Wk. Low | 1.3600 |
52 Wk. High | 11.9200 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -14.31M | - |
Diluted EPS | -0.49 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.52 | - |
Q1 2024 | -$0.50 | -$0.49 |
Q4 2023 | -$0.47 | -$0.52 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
19.00+3.71% | |
0.9830+428.49% | |
CAVA Group, Inc.CAVA | 82.93+6.87% |